Natera, Inc. (NTRA) Stock Profile — Insider Trades & Financials

Revenue$665.5M

Net Income$47.3M

EPS$-1.52

Market Cap$29.1B

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Steve Chapman

CEO & Executive Director

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California and Austin, Texas.

Founded: 2004
Employees: 3,018
Headquarters: AUSTIN, TX, United States
Website

⚡

Core Efficiency

ROE?

2.76%

ROA?

1.97%

D/E Ratio?

0.40

Op. Margin?

-3.42%

📊

Profitability Ratios

Net Margin?

7.10%

Loading company sections...

Natera, Inc.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness